An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants
Arch Dis Child. 2024 Jul 8:archdischild-2024-327040. doi: 10.1136/archdischild-2024-327040. Online ahead of print. ABSTRACT OBJECTIVE: To compare immunological responses of preterm infants to a four-component meningococcal …